These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 30803129)

  • 21. Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients.
    Swellam M; El Magdoub HM; Shawki MA; Adel M; Hefny MM; El-Shazly SS
    Curr Probl Cancer; 2021 Oct; 45(5):100709. PubMed ID: 33602501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA NEAT1 promotes the growth of cervical cancer cells via sponging miR-9-5p.
    Xie Q; Lin S; Zheng M; Cai Q; Tu Y
    Biochem Cell Biol; 2019 Apr; 97(2):100-108. PubMed ID: 30096244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of lncRNA H19 sensitizes melanoma cells to cisplatin by regulating the miR-18b/IGF1 axis.
    An LF; Huang JW; Han X; Wang J
    Anticancer Drugs; 2020 Jun; 31(5):473-482. PubMed ID: 32265386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer.
    Özgür E; Ferhatoğlu F; Şen F; Saip P; Gezer U
    Cancer Biomark; 2020; 27(1):11-17. PubMed ID: 31640083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA NEAT1 promotes the progression of hemangioma via the miR-361-5p/VEGFA pathway.
    Yu X; Liu X; Wang R; Wang L
    Biochem Biophys Res Commun; 2019 May; 512(4):825-831. PubMed ID: 30928097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells.
    Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
    J Biomed Sci; 2018 Feb; 25(1):11. PubMed ID: 29415742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer.
    Xiong H; Shen J; Chen Z; Yang J; Xie B; Jia Y; Jayasinghe U; Wang J; Zhao W; Xie S; Wang L; Zhou J
    Int J Oncol; 2020 Mar; 56(3):794-806. PubMed ID: 32124962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
    Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
    Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.
    Sun H; Wang G; Peng Y; Zeng Y; Zhu QN; Li TL; Cai JQ; Zhou HH; Zhu YS
    Oncol Rep; 2015 Jun; 33(6):3045-52. PubMed ID: 25846769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA NEAT1 correlates with higher disease risk, worse disease condition, decreased miR-124 and miR-125a and predicts poor recurrence-free survival of acute ischemic stroke.
    Li P; Duan S; Fu A
    J Clin Lab Anal; 2020 Feb; 34(2):e23056. PubMed ID: 31721299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p.
    Huang B; Liu C; Wu Q; Zhang J; Min Q; Sheng T; Wang X; Zou Y
    Biochem Biophys Res Commun; 2017 Jan; 482(4):828-834. PubMed ID: 27888106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silence of long noncoding RNA NEAT1 exerts suppressive effects on immunity during sepsis by promoting microRNA-125-dependent MCEMP1 downregulation.
    Chen JX; Xu X; Zhang S
    IUBMB Life; 2019 Jul; 71(7):956-968. PubMed ID: 30883005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression.
    Zhao D; Zhang Y; Wang N; Yu N
    Cancer Biomark; 2017 Sep; 20(3):247-254. PubMed ID: 28946559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA NEAT1 promotes colorectal cancer cell proliferation and migration via regulating glial cell-derived neurotrophic factor by sponging miR-196a-5p.
    Zhong F; Zhang W; Cao Y; Wen Q; Cao Y; Lou B; Li J; Shi W; Liu Y; Luo R; Chen C
    Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1190-1199. PubMed ID: 30383193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA NEAT1 Silenced miR-133b Promotes Migration and Invasion of Breast Cancer Cells.
    Li X; Deng S; Pang X; Song Y; Luo S; Jin L; Pan Y
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.
    Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E
    J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
    Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b.
    Wei X; Tao S; Mao H; Zhu H; Mao L; Pei W; Shi X; Shi Y; Zhang S; Wu Y; Wei K; Wang J; Pang S; Wang W; Chen C; Yang Q
    Gene; 2023 Apr; 860():147230. PubMed ID: 36717039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.